| Literature DB >> 29739976 |
Chin-Yu Chen1, Tzu-Ping Ko2, Kuan-Fu Lin3, Bo-Lin Lin4, Chun-Hsiang Huang5, Cheng-Hung Chiang5, Jia-Cherng Horng6.
Abstract
Ketol-acid reductoisomerase (KARI) is a bifunctional enzyme in the second step of branched-chain amino acids biosynthetic pathway. Most KARIs prefer NADPH as a cofactor. However, KARI with a preference for NADH is desirable in industrial applications including anaerobic fermentation for the production of branched-chain amino acids or biofuels. Here, we characterize a thermoacidophilic archaeal Sac-KARI from Sulfolobus acidocaldarius and present its crystal structure at a 1.75-Å resolution. By comparison with other holo-KARI structures, one sulphate ion is observed in each binding site for the 2'-phosphate of NADPH, implicating its NADPH preference. Sac-KARI has very high affinity for NADPH and NADH, with K M values of 0.4 μM for NADPH and 6.0 μM for NADH, suggesting that both are good cofactors at low concentrations although NADPH is favoured over NADH. Furthermore, Sac-KARI can catalyze 2(S)-acetolactate (2S-AL) with either cofactor from 25 to 60 °C, but the enzyme has higher activity by using NADPH. In addition, the catalytic activity of Sac-KARI increases significantly with elevated temperatures and reaches an optimum at 60 °C. Bi-cofactor utilization and the thermoactivity of Sac-KARI make it a potential candidate for use in metabolic engineering or industrial applications under anaerobic or harsh conditions.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29739976 PMCID: PMC5940873 DOI: 10.1038/s41598-018-25361-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Biosynthetic pathways for BCAA. In the first reaction acetolactate synthase (ALS) condenses one pyruvate with another into 2-acetoacetate (for valine and leucine) or with 2-ketobutyrate to form 2-aceto-2-hydroxybutyrate (for isoleucine). Both products are then isomerized and reduced via keto-acid reductoisomerase (KARI) to form 2,3-dihydroxyisovalerate and 2,3-dihydroxy-3-methylvalerate, respectively. In this unusual two-step reaction, each substrate undergoes Mg2+-dependent alkyl migration followed by NAD(P)H-dependent reduction of the 2-keto group. Dihydroxyacid dehydratase (DHAD) converts two products of the second step to 2-ketoisovalerate and 2-keto-3-methylvalerate, respectively. The final step in the parallel pathway is conducted catalysed by amino transferase, which yields the final products of valine from 2-ketoisovalerate and isoleucine from 2-keto-3-methylvalerate. In contrast, a series of more additional enzymes are necessary to sequentially divert 2-ketoisovalerate to the leucine production pathway.
Figure 2CD spectra of Sac-KARI in phosphate buffer (pH 8.0) containing 2 mM Mg2+. (A) The far-UV CD spectra of Sac-KARI measured over the wavelength range 200 to 260 nm at temperatures from 25 to 95 °C. (B) The far-UV CD spectra show that the secondary structure of Sac-KARI is unaffected by changes in pH over the range of pH values from 3.0 to 8.0. (C) CD-monitored thermal unfolding curve of Sac-KARI at 208 nm. Fitting of the thermal melting curve indicates that the Tm of Sac-KARI is approximately 86 °C.
Data collection and refinement statistics for Sac-KARI.
| Data Collection | |
|---|---|
| Space group | |
| Unit-cell | 48.4, 90.8, 154.1 |
| Resolution (Å)a | 30.0–1.75 (1.81–1.75) |
| No. of unique reflections | 69,217 (6734) |
| Redundancy | 4.4 (4.5) |
| Completeness (%) | 99.4 (98.7) |
| Average I/σ(I) | 33.8 (2.7) |
| Average CC1/2 | 0.946 (0.809) |
| Rmerge (%) | 3.6 (57.7) |
|
| |
| Resolution (Å) | 30.0–1.75 (1.81–1.75) |
| No. of reflections (work) | 65,672 (4670) |
| No. of reflections (free) | 3479 (240) |
| Rwork (%)b | 17.5 (25.2) |
| Rfree (%) | 21.6 (29.4) |
| Average B (Å2)/No. of atoms | |
| Protein | 32.8/5144 |
| Water | 42.6/468 |
| Ion | 64.9/37 |
| EDO | 38.4/8 |
| RMSZ/RMSD bond lengths (Å) | 1.03/0.021 |
| RMSZ/RMSD bond angles (°) | 1.05/2.1 |
| Ramachandran plot (%) | |
| Most favoured | 96.5 |
| Allowed | 3.5 |
| Clash score/Percentilec | 3.45/98 |
| Overall score/Percentilec | 1.65/85 |
| PDB ID code | 5YEQ |
aThe values in parentheses show the statistics for the highest-resolution shells.
bRwork = (Σhkl ||Fo| − |Fc||)/Σhkl |Fo|. Rfree was calculated with 2.9% of the data excluded from refinement.
cCalculated by MolProbity.
Figure 3Crystal structure of Sac-KARI. (A) A dimer comprising the asymmetric unit is shown as a ribbon model with the monomers coloured green and cyan. The N and C termini are indicated, as are the Rossmann and knot domains and a few secondary structural elements of interest, which are coloured yellow. The bound sulphate and magnesium ions are shown as stick-and-sphere models. (B) The second sulphate interacts with the β2-αB loop. It can form hydrogen bonds with R49 and S53, as does the 2′-phosphate of NADPH. (C) Magnesium binding. The bound magnesium ion is shown as a purple sphere. The surrounding acidic side chains are shown as stick models. D191 is from the second monomer, which is coloured cyan rather than green.
Kinetic parameters for the activity of KARI variants towards 2(S)-acetolactate in the presence of saturating concentrations of NADH or NADPH.
| Enzyme (class)/cofactor | Origin | T (°C) | Mg2+ (mM) | Ref | |||
|---|---|---|---|---|---|---|---|
| Sac-KARI (I)/NADPH |
| 25 | 2 | 184 ± 5 | 0.058 ± 0.001 | 0.32 ± 0.01 | This work |
| 10 | 140 ± 6 | 0.068 ± 0.001 | 0.49 ± 0.02 | ||||
| 37 | 2 | 157 ± 3 | 0.192 ± 0.000 | 1.23 ± 0.02 | |||
| 10 | 74 ± 5 | 0.195 ± 0.002 | 2.63 ± 0.14 | ||||
| 60 | 2 | 93 ± 5 | 0.957 ± 0.003 | 10.30 ± 0.55 | |||
| 10 | 60 ± 4 | 0.876 ± 0.003 | 14.58 ± 0.92 | ||||
| Sac-KARI (I)/NADH |
| 25 | 2 | 469 ± 4 | 0.05 5 ± 0.001 | 0.12 ± 0.00 | |
| 10 | 188 ± 5 | 0.06 2 ± 0.000 | 0.33 ± 0.01 | ||||
| 37 | 2 | 165 ± 3 | 0.157 ± 0.001 | 0.95 ± 0.02 | |||
| 10 | 99 ± 2 | 0.164 ± 0.002 | 1.66 ± 0.03 | ||||
| 60 | 2 | 144 ± 7 | 0.526 ± 0.013 | 3.66 ± 0.16 | |||
| 6 | 91 ± 4 | 0.444 ± 0.001 | 4.88 ± 0.22 | ||||
| Mr-KARI (I)/NADPH |
| 50 | 10 | 80 ± 10 | 0.77 ± 0.01 | 9.6 ± 1.8 |
[ |
| Mr-KARI (I)/NADH |
| 50 | 10 | 550 ± 60 | 0.50 ± 0.01 | 0.9 ± 0.2 |
[ |
| Mt-KARI (I)/NADPH |
| 37 | 4 | 110 ± 4 | 1.4 ± 0.02 | 12.73 |
[ |
| Sa-KARI (I)/NADPH |
| 25 | 50 | 285 ± 41 | 0.23 ± 0.01 | 0.81 |
[ |
| Re-KARI (I)/NADPH |
| 30 | 3 | 6200 | 0.115 (0.191) | 0.018 |
[ |
| Ec-KARI (II)/NADPH |
| 37 | 10 | 250 ± 30 | 2.23 ± 0.1 | 9.02 |
[ |
| Ec-KARI (II)/NADPH |
| 37 | 4 | 500 | 1.2 | 2.4 |
[ |
| Os-KARI (II)/NADPH | 37 | 4 | 11.67 | 1.4 | 120 |
[ | |
| So-KARI (II)/NADPH | 30 | 3 | 10 | 1.33 (1.4) | 133 |
[ | |
| Hv-KARI (II)/NADPH | 25 | 5 | 11 | 0.157 (0.16) | 14.27 |
[ | |
| Ec-KARI (II)/NADPH |
| 25 | 10 | 280 ± 30 | 2 ± 0.097 | 7.142 ± 0.689 |
[ |
| Sco1-KARI (I)/NADPH |
| 25 | 10 | 1600 ± 200 | 1.1 ± 0.2 | 0.687 ± 0.043 |
[ |
| Sco2-KARI (I)/NADPH |
| 25 | 10 | 12000 ± 800 | 0.24 ± 0.01 | 0.02 ± 0.0032 |
[ |
| Sli1-KARI (I)/NADPH |
| 25 | 10 | 1200 ± 70 | 0.7 ± 0.59 | 0.583 ± 0.064 |
[ |
| Sli2-KARI (I)/NADPH |
| 25 | 10 | 9300 ± 800 | 0.28 ± 0.02 | 0.03 ± 0.0038 |
[ |
| Sam-KARI (I)/NADPH |
| 25 | 10 | 2000 ± 150 | 0.63 ± 0.5 | 0.315 ± 0.033 |
[ |
| Sav-KARI (I)/NADPH |
| 25 | 10 | 800 ± 90 | 0.24 ± 0.2 | 0.3 ± 0.039 |
[ |
| Sgr-KARI (I)/NADPH |
| 25 | 10 | 1200 ± 700 | 0.42 ± 0.04 | 0.35 ± 0.037 |
[ |
| Spr-KARI (I)/NADPH |
| 25 | 10 | 9000 ± 700 | 3.6 ± 0.3 | 0.4 ± 0.038 |
[ |
| Svi2-KARI (I)/NADPH |
| 25 | 10 | 1800 ± 900 | 2 ± 0.07 | 1.111 ± 0.115 |
[ |
| Cgl-KARI (I)/NADPH |
| 25 | 10 | 8000 ± 900 | 3.2 ± 0.4 | 0.4 ± 0.015 |
[ |
The value in parentheses is the original value shown in literature and has the units μmol min−1 mg−1. In this work, enzyme activities were determined in 100 mM potassium phosphate at pH 8.0 with 220 μM NADPH or NADH, 2–10 mM MgSO4 and appropriate dilutions of 2S-AL in the concentration ranged from 0.0625 to 5.5 mM.
Kinetic parameters of KARI variants determined using NADPH or NADH with saturating concentrations of 2S-AL as substrate.
| Origin | β2-αB loop | NADH/NADPH ratio of | Cofactor preference | Ref | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NADH | NADPH | NADH | NADPH | NADH | NADPH | ||||||
| Sac-KARI |
| LEREGNS | 6.0 ± 0.8 | 0.4 ± 0.2 | 0.056 ± 0.001 | 0.064 ± 0.001 | 9.5 ± 1.3 | 185.8 ± 80.5 | 0.051 | NADPH | This work |
| Ia-KARI |
| LERQGDS | <1 | <1 | 0.02 | 0.03 | >20 | >25 | ~0.8 | Bispecific |
[ |
| Ms-KARI |
| LEREGKS | 24 | 31 | 0.06 | 0.07 | 2.5 | 2.1 | 1.2 | Bispecific |
[ |
| Hs-KARI | LDDKSPH | 39 | 46 | 0.12 | 0.12 | 3.2 | 2.7 | 1.2 | Bispecific |
[ | |
| Sw-KARI |
| LRKPFDEASEKE | 57 | 44 | 0.28 | 0.22 | 5.0 | 5.0 | 1.0 | Bispecific |
[ |
| Tp-KARI |
| DIPSSEN | <1 | 40 | 0.46 | 0.25 | >460 | 6.0 | 74 | NADH |
[ |
| Ua-KARI | Uncultured Archaeon | ETEILGGNKNPS | 1.1 | 38 | 0.22 | 0.05 | 200 | 1.3 | 152 | NADH |
[ |
| Af-KARI |
| LPEWDKAT | 5.0 | 26 | 0.1 | 0.04 | 20 | 1.5 | 13 | NADH |
[ |
| Do-KARI |
| QLEGDAY | 32 | n.a. | 0.25 | n.a. | 8.0 | n.a. | — | NADH |
[ |
| Mr-KARI |
| LRPGSRN | 240 | 20 | 1.09 | 0.98 | 4.6 | 54.5 | 0.084 | NADPH |
[ |
| So-KARI | LRKGSNS | 101 | 1.7 | 0.95 | 1.33 | 9.4 | 782.4 | 0.012 | NADPH |
[ | |
| Se-KARI |
| LREGSSS | 45 | 1.0 | 0.41 | 0.8 | 9 | 800 | 0.011 | NADPH |
[ |
| Ec-KARI |
| LRKEAIAEKRAS | 1075 | 41 | 0.3 | 3.6 | 0.3 | 88 | 0.003 | NADPH |
[ |
| Ec-KARI6E6 |
| LRKE | 30 | 650 | 2.3 | 0.20 | 74 | 0.40 | 185 | NADH |
[ |
| Se-KARIDD |
| LREG | 113 | 880 | 0.97 | 0.10 | 9 | 0.11 | 81.8 | NADH |
[ |
| Se-KARIDDV |
| LREG | 47 | >1000 | 1.01 | 0.25 | 22 | 0.25 | 88 | NADH |
[ |
Ec-KARI6E6 mutant: A71S, R76D, S78D, Q110V; Se-KARIDD mutant: S61D, S63D; Se-KARIDDV mutant: S61D, S63D, I95V.
Sac-KARI: The Michaelis-Menten constants for the cofactors were measured with appropriate dilutions of NADPH and NADH (0.01~0.22 mM) in the presence of saturating concentrations of substrate 2S-AL (5 mM), 10 mM MgSO4 and 100 mM potassium phosphate at pH 8.0. Mr-KARI: the kinetic parameters measured at 50 °C.